Skip to main content
. Author manuscript; available in PMC: 2021 Sep 15.
Published in final edited form as: Clin Cancer Res. 2020 Nov 20;27(5):1371–1380. doi: 10.1158/1078-0432.CCR-20-3084

Table 2.

ORR and DRR per TC PD-L1 (≥1%) and log density of CD8+PD-1+TIM-3LAG-3 TIC levels (High vs Low) in the nivo arm.

Marker Combination Nivo (n = 111)a
n ORR% (n) DRR% (n)
PD-L1 High / CD8PD1+TIM3LAG3 TIC High 12 50% (6) 33% (4)
PD-L1 Low / CD8PD1+TIM3LAG3 TIC High 90 22% (20) 18% (16)
PD-L1 Low / CD8PD1+TIM3LAG3 TIC Low 9 11% (1) 0% (0)
Trend test 1-sided p-value 0.027 0.045
a

Association of the biomarkers with ORR and DRR was not assessed in the evero arm due to the low number of responders.